7.96BMarket Cap
154.37P/E TTM
Key Figures
143.810Open
145.000High
875.27KVolume
154.37P/E TTM
53.73P/E Dynamic
--Dividend TTM
1.55%Turnover Ratio
143.600Prev. Close
139.398Low
95.60MTurnover
LossP/E Static
3.77P/B
0.00%Div Yield TTM
1.78%ROA
175.77052wk High
0.56Volume Ratio
-25.51MNet Profit
56.33MShares
0.9135EPS TTM
1.09Beta
2.51%ROE
100.99052wk Low
3.90%Amplitude
53.91%Gross Margin
7.96BMarket Cap
0.30Reward/Risk
2.77%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Repligen Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 22 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 187.05.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Repligen Corp Highlights
StrengthsRisks
Repligen Corp News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Zimmer Biomet Holdings Inc
ZBH
31
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Repligen Corp Info
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.
Ticker SymbolRGEN
CompanyRepligen Corp
CEOLoeillot (Olivier)
Websitehttps://www.repligen.com/
Shareholders
FAQs
What is the current price of Repligen Corp (RGEN)?
The current price of Repligen Corp (RGEN) is 141.03.
What is the symbol of Repligen Corp?
The ticker symbol of Repligen Corp is RGEN.
What is the 52-week high of Repligen Corp?
The 52-week high of Repligen Corp is 175.77.
What is the 52-week low of Repligen Corp?
The 52-week low of Repligen Corp is 100.99.
What is the market capitalization of Repligen Corp?
The market capitalization of Repligen Corp is 7.94B.
Is Repligen Corp (RGEN) currently rated as Buy, Hold, or Sell?
According to analysts, Repligen Corp (RGEN) has an overall rating of Buy, with a price target of 187.05.
What is the Earnings Per Share (EPS TTM) of Repligen Corp (RGEN)?
The Earnings Per Share (EPS TTM) of Repligen Corp (RGEN) is 0.87.
